3D MRI Assessment of Femoroacetabular Impingement in Patients With ACL Rupture - Exploratory Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche

About this trial

Anterior cruciate ligament (ACL) tears are among the most common sports injuries. Numerous studies have shown that reduced hip rotation may play a role in ACL tears. The same question may also arise for hip injuries such as femoroacetabular impingement (FAI).

This research is based on the hypothesis that there is a relationship between FAI and ACL injury. In this context, 3D MRI of the hip would provide morphological details of the hip that are not currently available with other imaging techniques, thereby enabling early identification of FAI. This is the reason why this research has been initiated.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient, male or female, aged 18 years or older

Patient with a primary complete ACL rupture

Patient affiliated with or covered by a social security scheme

Patient who speaks French and has signed an informed consent form

Disqualifiers

Patient with multi-ligament injury

Patients with a history of hip fracture

Patients with a history of hip surgery

Patients with a contraindication to MRI

Trial design

Design model

Single group

Treatments tested in this trial

  • 3D MRI

    Other intervention

    Intervention consists of performing a 3D MRI scan of both hips using a T1 sequence.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: FAI armExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

FAI (femoroacetabular impingement) prevalence

Prevalence of femoroacetabular impingement will be expressed as %. It will be measured on the injured knee side (i.e., ACL rupture) and on the healthy knee side (i.e., uninjured).

Time frame
Day 1

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: